68 results on '"Hechter, Rulin C."'
Search Results
2. Changes in Body Mass Index Over Time in People With and Without HIV Infection
3. 1551. Changes in Glomerular Filtration Rate after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
4. Initial antiretroviral therapy regimen and risk of heart failure
5. Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins
6. Chronic and Sustained High-Dose Opioid Use in an Integrated Health System
7. Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
8. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection
9. Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System—A Cohort Study
10. Factors Associated With Firearm Injury Among Pediatric Members of a Large Integrated Healthcare System
11. The association between buprenorphine treatment duration and mortality: a multi‐site cohort study of people who discontinued treatment
12. Multimorbidity Burden and Incident Heart Failure Among People With and Without HIV: The HIV-HEART Study
13. Changes in Testing and Diagnoses of Sexually Transmitted Infections and HIV During the COVID-19 Pandemic
14. Transgender Care Experiences, Barriers, and Recommendations for Improvement in a Large Integrated Health Care System in the United States
15. Human Immunodeficiency Virus Infection and Variation in Heart Failure Risk by Age, Sex, and Ethnicity: The HIV HEART Study
16. Identifying Suicidal Ideation and Attempt From Clinical Notes Within a Large Integrated Health Care System
17. HIV Infection and Risks of Morbidity and Death in Adults with Incident Heart Failure
18. Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System
19. Referral Linkage to Preexposure Prophylaxis Care and Persistence on Preexposure Prophylaxis in an Integrated Health Care System
20. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes
21. The Use of Natural Language Processing to Ascertain Suicide Ideation/Attempt from Clinical Notes Within a Large Integrated Healthcare System (Preprint)
22. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV
23. 80. COVID-19 Testing, Characteristics, and Outcomes Among People Living with HIV in an Integrated Health System
24. Validity of diagnosis and procedure codes for identifying neural tube defects in infants
25. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
26. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems
27. Prevalence and treatment of opioid use disorders among primary care patients in six health systems
28. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
29. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness
30. Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine
31. Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012–13, 2013–14, and 2014–15
32. Chronic pain diagnoses and opioid dispensings among individuals with serious mental illness
33. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV
34. The Association between Medical Comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) Measures of Treatment Initiation and Engagement for Alcohol and other Drug use Disorders
35. Psychiatric Comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) Measures of Alcohol and other Drug Treatment Initiation and Engagement across 7 Health Care Systems
36. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) Treatment Initiation and Engagement among Patients with Opioid use Disorder across 7 Health Systems
37. Factors Associated with Healthcare Effectiveness Data and Information Set (HEDIS) Alcohol and other Drug Measure Performance in 2014–2015
38. Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project
39. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis
40. Safety of Influenza Vaccination Administered During Hospitalization
41. Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings
42. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems
43. Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus
44. Effect of an Electronic Alert on Targeted HIV Testing Among High-Risk Populations
45. Infant Hospitalizations and Mortality After Maternal Vaccination
46. Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2–10 Years
47. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy
48. Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization
49. Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds
50. 530: Maternal and infant outcomes following inadvertent hpv vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.